Advancing Translation of Preclinical Knowledge to Optimize Neuroinflammatory Targeting & Enhance Patient Response

Time: 12:00 pm
day: Pre-Conference Workshop Day (A+B)


Translatability is proving one of the biggest barriers for neuroimmunology drugs reaching the clinic. By addressing

the translational limitations exhibited by preclinical neuroglial models, this workshop will provide actionable takeaways to enhance your pipeline of neuroinflammatory targeted therapeutics into trials.

Attendees will discuss in detail:

  • Selecting the right disease pathology to effectively test the target of interest
  • Optimizing the time of intervention during CNS inflammatory progression
  • Determining how therapeutic intervention will impact neuroinflammatory states and how these modulations will be assessed